Problems with pulmonary toxicity have emerged as a potentially limiting factor for
amiodarone use. We studied 24 consecutive patients receiving low-dose (ie,≤ 400 mg/day) …

Amiodarone is an investigational antiarrhythmic agent known to cause pulmonary toxicity.
This report describes two patients with previous amiodarone pulmonary toxicity and …

Abstract purpose: Amiodarone has proven to be effective in many cases of cardiac
arrhythmias, refractory ventricular tachycardia, and ventricular fibrillation. Pulmonary toxicity …

Abstract Pulmonary toxicity developed in 15 (17%) of 89 patients treated with amiodarone
during a follow-up period of 2 weeks to 54 (mean 20±15) months. Prospective evaluation of …

Reports of pulmonary infiltrates in patients taking amiodarone, initiated the study of 69
patients for pulmonary toxicity using serial chest roentgenograms (CXRs), pulmonary …

The incidence and clinical predictors of amiodarone pulmonary toxicity were examined in
573 patients treated with amiodarone for recurrent ventricular (456 patients) or …

Rationale: Although there have been reports of pulmonary toxicity with low-dose
amiodarone, it is generally believed that low-dose therapy is safe. Methods: The clinical data …

Forty-three patients treated with amiodarone hydrochloride with an average daily dose of
204.7+/-79.4 mg/day for a mean period of 37.1+/-25.3 months, were studied by clinical …

Previous studies have reported an incidence of amiodarone-induced pulmonary toxicity
(AIPT) of 5% to 10% with high doses of amiodarone (greater than 400 mg daily). A lower rate …

A prospective study was conducted of 189 patients treated with amiodarone, maintained at
doses of 400 to 800 mg/day and followed for up to 6 years. Only patients who had life …